Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444905) titled 'Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma' on Feb. 24.

Study Type: Observational [Patient Registry]

Primary Sponsor: Tongji Hospital

Condition: HCC - Hepatocellular Carcinoma Machine Learning Evaluation

Intervention: Other: Machine Learning-Based Risk Assessment

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2023

Target Sample Size: 800

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07444905

Published by HT Digital Content Services with permission from Health Daily D...